Abaloparatide Real-World Patient Experience Study.

ANABOLICS HEALTH SERVICES RESEARCH OSTEOPOROSIS

Journal

JBMR plus
ISSN: 2473-4039
Titre abrégé: JBMR Plus
Pays: England
ID NLM: 101707013

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 13 08 2020
revised: 01 12 2020
accepted: 16 12 2020
entrez: 29 3 2021
pubmed: 30 3 2021
medline: 30 3 2021
Statut: epublish

Résumé

Despite the availability of various osteoporosis treatments, adherence remains suboptimal. One contributing factor may be patient experience with therapy. This US, multicenter, combined retrospective chart review and patient questionnaire study included postmenopausal women at high risk for fracture and is the first study to describe real-world patient experience with abaloparatide (ABL) injection. Eight geographically diverse secondary care sites in the United States participated (

Identifiants

pubmed: 33778325
doi: 10.1002/jbm4.10457
pii: JBM410457
pmc: PMC7990148
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e10457

Informations de copyright

© 2020 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.

Références

Clin Ther. 2006 Feb;28(2):236-42
pubmed: 16678644
Osteoporos Int. 2014 Oct;25(10):2359-81
pubmed: 25182228
Osteoporos Int. 2007 Oct;18(10):1311-7
pubmed: 17585359
Expert Rev Pharmacoecon Outcomes Res. 2010 Dec;10(6):677-89
pubmed: 21155701
Am J Med. 2009 Feb;122(2 Suppl):S3-13
pubmed: 19187810
Arch Osteoporos. 2016 Dec;11(1):33
pubmed: 27739032
Am J Med. 2006 Apr;119(4 Suppl 1):S32-7
pubmed: 16563940
Health Qual Life Outcomes. 2009 Apr 27;7:36
pubmed: 19397800
Osteoporos Int. 2012 Feb;23(2):733-41
pubmed: 21625886
Clinics (Sao Paulo). 2012 Nov;67(11):1315-20
pubmed: 23184210
Ann Pharmacother. 2012 May;46(5):659-70
pubmed: 22510666
Osteoporos Int. 2008 Apr;19(4):385-97
pubmed: 18292978
JAMA. 2016 Aug 16;316(7):722-33
pubmed: 27533157
Osteoporos Int. 2014 Jun;25(6):1775-84
pubmed: 24737386
J Bone Miner Res. 2017 Jan;32(1):17-23
pubmed: 27612281
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52
pubmed: 22588748
J Manag Care Spec Pharm. 2015 Sep;21(9):824-33, 833a
pubmed: 26308229
Osteoporos Int. 2005 May;16(5):447-55
pubmed: 15609073
Value Health. 2011 Jun;14(4):571-81
pubmed: 21669382
BMC Womens Health. 2010 Aug 20;10:26
pubmed: 20727140

Auteurs

Deborah T Gold (DT)

Departments of Psychiatry & Behavioral Sciences and Sociology Duke University Medical Center Durham NC USA.

Richard Weiss (R)

Global Medical Affairs Radius Health, Inc. Waltham MA USA.

Tammy Beckett (T)

Department of Orthopaedics Orthopaedic Associates of Grand Rapids Research and Education Institute Grand Rapids MI USA.

Chad Deal (C)

Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatology The Cleveland Clinic Foundation Cleveland OH USA.

Robert S Epstein (RS)

Epstein Health, LLC Woodcliff Lake NJ USA.

Andrew L James (AL)

Adult Health CNS Proactive Orthopaedics Proactive Orthopaedics at Columbia Orthopaedic Groups LLP Columbia MO USA.

Jacqueline M Kernaghan (JM)

Osteoporosis Center of Delaware County Prospect Health Access Network Springfield PA USA.

Mahshid Mohseni (M)

Department of Medicine, Division of Bone and Mineral Diseases Washington University School of Medicine St Louis MO USA.

Michael Spiegel (M)

WCMG Rheumatology Western Connecticut Health Network Danbury CT USA.

Tamara Vokes (T)

Department of Medicine, Section of Endocrinology University of Chicago Chicago IL USA.

Jenna Roberts (J)

Observational Research Adelphi Real World Bollington, Macclesfield UK.

Tom Bailey (T)

Observational Research Adelphi Real World Bollington, Macclesfield UK.

Yamei Wang (Y)

Biometrics Radius Health, Inc. Waltham, MA USA.

Setareh A Williams (SA)

Health Economics and Outcomes Research Radius Health, Inc. Waltham, MA USA.

Classifications MeSH